GlassScriptPhysician profile
Ray J Kieffer, JR.
NPI 1740458314
$3,559.52
in general payments reported to CMS, 2019-2025
8 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $2,008 · 2021: $108 · 2022: $126 · 2023: $343 · 2024: $49.64 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $125 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.58 |
| Education | $125.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3m Company | $2,291.87 | 2019-2022 | |
| Align Technology, INC. | $670.78 | 2019-2025 | Invisalign, Invisalign Touch Up, Itero Element 5d Plus |
| USA Angelalign Technology Corp | $284.38 | 2023-2025 | |
| Scican INC | $205.00 | 2019 | |
| Solventum Corporation | $33.30 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.92 | 2023 | Lifevest |
| Lightforce Orthodontics, INC. | $26.25 | 2023 | |
| Straumann USA LLC | $15.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Kieffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.